Stroke Severity Is a Crucial Predictor of Outcome: An International Prospective Validation Study
暂无分享,去创建一个
A. Bottle | G. Rinkel | V. Thijs | N. Rost | J. Lee | T. Hemmen | S. Middleton | M. Randall | L. Shaw
[1] C. Wolfe,et al. Derivation and External Validation of a Case Mix Model for the Standardized Reporting of 30-Day Stroke Mortality Rates , 2014, Stroke.
[2] P. Deyn,et al. Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke , 2014, Clinical Neurology and Neurosurgery.
[3] J. Broderick,et al. Stroke Outcomes Measures Must Be Appropriately Risk Adjusted to Ensure Quality Care of Patients: A Presidential Advisory From the American Heart Association/American Stroke Association , 2014, Stroke.
[4] R. Rosenfeld. Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[5] A. Bottle,et al. Global comparators project: international comparison of hospital outcomes using administrative data. , 2013, Health services research.
[6] Tzu-Ching Wu,et al. Optimizing Prediction Scores for Poor Outcome After Intra-Arterial Therapy in Anterior Circulation Acute Ischemic Stroke , 2013, Stroke.
[7] V. Durkalski,et al. The effect of covariate adjustment for baseline severity in acute stroke clinical trials with responder analysis outcomes , 2013, Trials.
[8] David S Liebeskind,et al. Importance of proper patient selection and endpoint selection in evaluation of new therapies in acute stroke: further analysis of the SENTIS trial , 2013, Journal of NeuroInterventional Surgery.
[9] Adrian F Hernandez,et al. Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. , 2012, JAMA.
[10] Jeffrey L. Saver,et al. Relationship Between Neurologic Deficit Severity and Final Functional Outcome Shifts and Strengthens During First Hours After Onset , 2012, Stroke.
[11] Eric E. Smith,et al. Predictors of Increased Intravenous Tissue Plasminogen Activator Use Among Hospitals Participating in the Massachusetts Primary Stroke Service Program , 2012, Circulation. Cardiovascular quality and outcomes.
[12] Eric E. Smith,et al. Are Quality Improvements in the Get With The Guidelines-Stroke Program Related to Better Care or Better Data Documentation? , 2011, Circulation. Cardiovascular quality and outcomes.
[13] J. Switzer,et al. Simplified Modified Rankin Scale Questionnaire: Reproducibility Over the Telephone and Validation With Quality of Life , 2011, Stroke.
[14] J. Saver,et al. Disability status at 1 month is a reliable proxy for final ischemic stroke outcome , 2010, Neurology.
[15] Askiel Bruno,et al. Improving Modified Rankin Scale Assessment With a Simplified Questionnaire , 2010, Stroke.
[16] D. Mozaffarian,et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[17] D. Mozaffarian,et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[18] Eric E. Smith,et al. Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke , 2010, Circulation. Cardiovascular quality and outcomes.
[19] P. M. Janssen,et al. Comparison of Telephone and Face-to-Face Assessment of the Modified Rankin Scale , 2009, Cerebrovascular Diseases.
[20] J. Saver,et al. Day-90 Acute Ischemic Stroke Outcomes Can Be Derived from Early Functional Activity Level , 2009, Cerebrovascular Diseases.
[21] M. Walters,et al. Reliability of the Modified Rankin Scale: A Systematic Review , 2009, Stroke.
[22] V. Feigin,et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review , 2009, The Lancet Neurology.
[23] Ralph L. Sacco,et al. Stroke Outcome in Clinical Trial Patients Deriving From Different Countries , 2009, Stroke.
[24] Christian Weimar,et al. Predicting Long-Term Outcome After Acute Ischemic Stroke: A Simple Index Works in Patients From Controlled Clinical Trials , 2008, Stroke.
[25] S. Downie,et al. Ictal eye closure is a reliable indicator for psychogenic nonepileptic seizures , 2006, Neurology.
[26] Jamie L Banks,et al. Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials: A Literature Review and Synthesis , 2007, Stroke.
[27] J. Saver,et al. Confirmation of tPA Treatment Effect by Baseline Severity-Adjusted End Point Reanalysis of the NINDS-tPA Stroke Trials , 2007, Stroke.
[28] R. Sacco,et al. Quality improvement in acute stroke , 2006, Neurology.
[29] Jan Potter,et al. Reliability of the Modified Rankin Scale Across Multiple Raters: Benefits of a Structured Interview , 2005, Stroke.
[30] J. Swieten. Interobserver Agreement for the Assessment of Handicap in Stroke Patients , 2005 .
[31] Georg Heinze,et al. Comparing the importance of prognostic factors in Cox and logistic regression using SAS , 2003, Comput. Methods Programs Biomed..
[32] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[33] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[34] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[35] R. Bloch,et al. Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.
[36] Jacob Cohen,et al. Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. , 1968 .
[37] J. Rankin. Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis , 1957, Scottish medical journal.